SIRT1 as a Therapeutic Target in Diabetic Complications
Journal:
Current Medicinal Chemistry
Volume:
25
Page:
1002-1035
Author(s):
Justyna Strycharz, Zaneta Rygielska, Ewa Swiderska, Jozef Drzewoski, Janusz Szemraj, Leszek Szmigiero and Agnieszka Sliwinska*
Gut Microbiota as a Therapeutic Target for Metabolic Disorders
Journal:
Current Medicinal Chemistry
Volume:
25
Page:
984-1001
Author(s):
Hirofumi Okubo, Yusuke Nakatsu, Akifumi Kushiyama, Takeshi Yamamotoya, Yasuka Matsunaga, Masa-ki Inoue, Midori Fujishiro, Hideaki Sakoda, Haruya Ohno, Masayasu Yoneda, Hiraku Ono and Tomoichiro Asano*
The Prevalence of Dyslipidemia and Other Cardiovascular Risk Factors in Youth with Diabetes
Journal:
Current Pediatric Reviews
Volume:
13
Page:
277-280
Author(s):
Treatment Strategies for Hypercholesterolemia
Journal:
Current Pediatric Reviews
Volume:
13
Page:
243-254
Author(s):
Jacob Hartz and Sarah Clauss*
Retromer Dysfunction and Neurodegenerative Disease
Journal:
Current Genomics
Volume:
19
Page:
279-288
Author(s):
Christiane Reitz*
Roles of Perilipins in Diseases and Cancers
Journal:
Current Genomics
Volume:
19
Page:
247-257
Author(s):
Pengpeng Zhang, Lian Meng, Lingxie Song, Juan Du, Shutong Du, Wenwen Cui, Chunxia Liu* and Feng Li*
Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
Journal:
Current Vascular Pharmacology
Volume:
16
Page:
269-275
Author(s):
Paschalis Paschos, Vasilios G. Athyros, Achilleas Tsimperidis, Anastasia Katsoula, Nikolaos Grammatikos and Olga Giouleme*
A Critical Approach of Guideline Therapeutic Recommendations for NAFLD
Journal:
Current Vascular Pharmacology
Volume:
16
Page:
228-238
Author(s):
Dragan B. Djordjevic, Marija Zdravkovic, Aleksandar Nagorni, Athanasios Manolis, Costas Tsioufis and Dragan Lovic*
Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
Journal:
Current Vascular Pharmacology
Volume:
16
Page:
219-227
Author(s):
Niki Katsiki, Pablo Perez-Martinez, Panagiotis Anagnostis, Dimitri P. Mikhailidis* and Asterios Karagiannis
Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk
Journal:
Current Vascular Pharmacology
Volume:
16
Page:
246-253
Author(s):
Vasilios G. Athyros*, Chrysa Boutari, Konstantinos Stavropoulos, Panagiotis Anagnostis, Konstantinos P. Imprialos, Michael Doumas and Asterios Karagiannis